Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-025464

EVP & Chief Medical Officer sold 6,770 shares at an average $4.05 ($27,416)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Rangwala Reshma · EVP & Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-20 Sale : show line 1 in the form 10b5-1 −115 $4.03 $463 164,885 D
2023-04-20 Sale : show line 2 in the form 10b5-1 −6,655 $4.05 $26,953 158,230 D
Open-market sales · 6,770 sh · avg $4.05 · $27,416
Loading xslF345X04/doc4.xml…